Prognostic Value of Masked Uncontrolled Hypertension
- PMID: 30354717
- PMCID: PMC6205750
- DOI: 10.1161/HYPERTENSIONAHA.118.11499
Prognostic Value of Masked Uncontrolled Hypertension
Abstract
The prognostic relevance of masked uncontrolled hypertension (MUCH) is incompletely clear, and its global impact on cardiovascular outcomes and mortality has not been assessed. The aim of this study was to perform a meta-analysis on the prognostic value of MUCH. We searched for articles assessing outcome in patients with MUCH compared with those with controlled hypertension (CH) and reporting adjusted hazard ratio and 95% CI. We identified 6 studies using ambulatory blood pressure monitoring (12 610 patients with 933 events) and 5 using home blood pressure measurement (17 742 patients with 394 events). The global population included 30 352 patients who experienced 1327 events. Selected studies had cardiovascular outcomes and all-cause mortality as primary outcome, and the main result is a composite of these events. The overall adjusted hazard ratio was 1.80 (95% CI, 1.57-2.06) for MUCH versus CH. Subgroup meta-analysis showed that adjusted hazard ratio was 1.83 (95% CI, 1.52-2.21) in studies using ambulatory blood pressure monitoring and 1.75 (95% CI, 1.38-2.20) in those using home blood pressure measurement. Risk was significantly higher in MUCH than in CH independently of follow-up length and types of studied events. MUCH was at significantly higher risk than CH in all ethnic groups, but the highest hazard ratio was found in studies, including black patients. Risk of cardiovascular events and all-cause mortality is significantly higher in patients with MUCH than in those with CH. MUCH detected by ambulatory or home blood pressure measurement seems to convey similar prognostic information.
Keywords: blood pressure; hypertension; masked hypertension; mortality; risk.
Conflict of interest statement
CONFLICT OF INTEREST
None.
Figures
Comment in
-
Masked Uncontrolled Hypertension.Hypertension. 2018 Oct;72(4):843-845. doi: 10.1161/HYPERTENSIONAHA.118.11640. Hypertension. 2018. PMID: 30354733 No abstract available.
References
-
- Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med1999;131:564–572. - PubMed
-
- Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] study). Circulation 2001;104:1385–1392. - PubMed
-
- Wing LM, Brown MA, Beilin LJ, Ryan P, Reid CM; ANBP2 Management Committee and Investigators. Second Australian National Blood Pressure Study. ‘Reverse white-coat hypertension’ in older hypertensives. J Hypertens 2002;20:639–644. - PubMed
-
- Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002;40:795–796. - PubMed
-
- Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 2011;24:52–58. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
